The firm plans to offer genome, gut microbiome, and epigenome analyses and will collaborate with nutritional supplement developer and majority shareholder Thorne.
The newly launched LunaDNA hopes that its community model of compensating individuals for contributing genomic and health information will lead to better research.
EncrypGen will integrate its genetics blockchain solution into the Health Wizz consumer health app, and will sell Codigo46's genetic testing product through its website.
According to the Federal Register notice, after a first time FDA marketing authorization, manufacturers can commercialize new GHR tests without additional review.
23andMe said it plans to use the money raised to grow its customer base, expand its therapeutics group, and invest in its genetic research platform.
Earlier this week, the company launched Genomic Explorer in the US, a web-based service that enables consumers to upload their genomic data for viewing and analysis.
Last month, Helix launched an online marketplace of consumer genomics applications including ones for fitness, ancestry, and disease risk.
The latest offering puts the genetic testing company on the path toward becoming what it calls a preventive health service company.
Illumina received more orders than expected for NovaSeq in Q2 and sees a big opportunity in the consumer genomics market for its array business and Helix.
Parent firm Gene by Gene calls the law "brief and vague" and is pushing for ancestry testing to be exempt from the provision of the genetic privacy statute.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.